KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Long-Term Investments (2016 - 2026)

HCA Healthcare (HCA) has disclosed Long-Term Investments for 17 consecutive years, with $387.0 million as the latest value for Q1 2026.

  • For Q1 2026, Long-Term Investments fell 29.64% year-over-year to $387.0 million; the TTM value through Mar 2026 reached $387.0 million, down 29.64%, while the annual FY2025 figure was $485.0 million, 14.76% down from the prior year.
  • Long-Term Investments hit $387.0 million in Q1 2026 for HCA Healthcare, down from $485.0 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $786.0 million in Q1 2023 and bottomed at $379.0 million in Q2 2022.
  • Average Long-Term Investments over 5 years is $544.6 million, with a median of $485.0 million recorded in 2025.
  • Year-over-year, Long-Term Investments surged 98.43% in 2023 and then tumbled 40.08% in 2024.
  • HCA Healthcare's Long-Term Investments stood at $381.0 million in 2022, then soared by 98.43% to $756.0 million in 2023, then decreased by 24.74% to $569.0 million in 2024, then fell by 14.76% to $485.0 million in 2025, then fell by 20.21% to $387.0 million in 2026.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $387.0 million, $485.0 million, and $654.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.